Clue found for failure of cholesterol-lowering drugsJune 17th, 2008 - 12:00 pm ICT by IANS
Washington, June 17 (IANS) A variation in the way a single protein is processed by the body might account for some people’s failure to respond to drugs that lower “bad” cholesterol, according to a new study. The gene variation, called alternative splicing, has helped explain the drugs’ decreased power to reduce low-density lipoprotein (LDL) in some participants.
The study is the first to show that a change in a biological process substantially modifies the effectiveness of cholesterol-lowering drugs, known as statins.
“The implications could go well beyond the efficacy of statins by helping us to understand the differences among individuals in how cholesterol is metabolised,” said Ronald Krauss, co-author of the study.
The discovery could lead to improved cholesterol treatment and new therapy for other chronic ailments.
Simvastatin is one of several statin drugs that can effectively reduce the risk of heart attacks in people with high cholesterol.
They work by blocking a key enzyme required for the production of cholesterol called HMGCR. However, all people don’t have the same response to statins.
Krauss and his team, seeking a genetic explanation for this variability, analysed differences in how the gene responsible for producing HMGCR was processed - or spliced - among more than 900 participants enrolled in the study.
- Statin can prevent strokes, besides lowering lipids - Jan 05, 2012
- 'Good' cholesterol drug may help diabetics - Jul 19, 2011
- Why statins work for some people, but not for all - Apr 22, 2010
- Single letter in human genome linked with elevated cholesterol levels identified - Jan 05, 2009
- New study raises questions over broader use of statins - Jun 29, 2010
- A jab could lower cholesterol by two-thirds - Nov 15, 2011
- Increasing blood levels of 'good' cholesterol 'cuts heart disease risk' - Nov 18, 2010
- Two therapies that may slow diabetic eye disease progression found - Jul 24, 2010
- Experts wary of Lancet's study on good cholesterol - Jun 14, 2012
- Statins may reduce septic lung damage - May 03, 2011
- Gut bugs could prevent efficacy of cholesterol drugs - Oct 14, 2011
- Statin use may cut risk of colorectal cancer - Oct 19, 2010
- How chocolates protect against heart disease - Feb 08, 2011
- Routine periodic fasting good for health, heart - Apr 04, 2011
- 'Bad cholesterol' also vital for health - May 06, 2011
Tags: alternative splicing, bad cholesterol, biological process, cholesterol, cholesterol lowering drugs, cholesterol treatment, chronic ailments, co author, efficacy, gene variation, genetic explanation, heart attacks, high cholesterol, krauss co, ldl, low density lipoprotein, ronald krauss, simvastatin, statin drugs, variability